ARCHIVES

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

This article is from The Cancer Letter archive.

Vol. 33 No. 29 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: NTP Invites Comments On Annual Carcinogen Report At April 21 Meeting; Robert Mosely Dies

March 27, 1987

NCI Official Says He Hopes to “Put More Money” Into SPOREs.

April 14, 2006

House Passes Bill On New Cigarette Labels

September 14, 1984

In Brief: Breast Cancer Coalition Seeks Survivors, Activists For 3-Day Course In Advocacy

April 28, 1995

NCI Reports On Efforts To Prevent Cancer In Native Americans

August 13, 1999

R01 Payline To Increase From 21st to 22nd Percentile; Barcelona Hospital Wins BMS Cancer Research Grant

June 14, 2002